A response to the Ethics Committee of the American Society of ReproductiveMedicine

In its recent statement 'Sex Selection and Preimplantation Genetic Diagnosi s', the Ethics Committee of the American Society of Reproductive Medicine c oncluded that preimplantation genetic diagnosis for sex selection for nonme dical reasons should be discouraged because it poses a risk of unwarranted gender bias, social harm, and results in the diversion of medical resources from genuine medical need. We critically examine the arguments presented a gainst sex selection using preimplantation genetic diagnosis. We argue that sex selection should be available, at least within privately funded health care.